https://www.selleckchem.com/pr....oducts/compound-3i.h
73, 95% confidence interval [CI] 1.70-4.37, P .001), history of lung disease (OR 1.70, 95% CI 1.06-2.70, P=.029), and history of heart failure (OR 2.44, 95% CI 1.10-5.45, P=.027). Adjusted 90-day mortality (22.4% vs 4.1%, hazard ratio 6.11, 95% CI 3.95-9.44, P .001) was higher, and median critical care length of stay (8.0 vs 4.0 days, P .001) was longer in patients managed with MCS. In a randomized controlled trial of high-risk cardiac surgical patients in North America, we observed patient, and surgical variables ass
Like
Comment
Share
